Biohaven Ltd.
BHVN
$15.00
$0.281.90%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.89% | -21.71% | -7.43% | 37.22% | 44.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.00% | -41.13% | -44.34% | -4.93% | 30.78% |
| Operating Income | 41.00% | 41.13% | 44.34% | 4.93% | -30.78% |
| Income Before Tax | 30.81% | 41.08% | 22.27% | -8.02% | 38.08% |
| Income Tax Expenses | 49.81% | -55.34% | 631.25% | 474.58% | 47.46% |
| Earnings from Continuing Operations | 30.70% | 41.12% | 22.10% | -8.20% | 38.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.70% | 41.12% | 22.10% | -8.20% | 38.03% |
| EBIT | 41.00% | 41.13% | 44.34% | 4.93% | -30.78% |
| EBITDA | 41.52% | 41.61% | 44.98% | 5.63% | -31.14% |
| EPS Basic | 52.91% | 59.33% | 34.50% | 3.50% | 46.88% |
| Normalized Basic EPS | 53.04% | 59.07% | 51.66% | 5.10% | -13.36% |
| EPS Diluted | 52.91% | 59.33% | 34.50% | 3.50% | 46.88% |
| Normalized Diluted EPS | 53.04% | 59.07% | 51.66% | 5.10% | -13.36% |
| Average Basic Shares Outstanding | 47.15% | 44.80% | 18.93% | 12.13% | 16.64% |
| Average Diluted Shares Outstanding | 47.15% | 44.80% | 18.93% | 12.13% | 16.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |